Literature DB >> 1281454

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays.

B Sallerfors1, T Olofsson.   

Abstract

The kinetics of GM-CSF and G-CSF secretion by purified adherent human monocytes were studied by quantitative immunoassays. Interleukin-1 (IL-1); 4-40 ng/ml and E. coli lipopolysaccharide (LPS); 0.1-1.00 ng/ml, were the most effective stimuli and induced dose-dependent secretion of both GM-CSF and G-CSF. Secretion of newly synthesized CSF was detectable 3-6 hours after stimulation and continued for approximately 24 h. Twenty minutes pulse exposure to LPS was sufficient to induce half maximum secretion of GM-CSF, and after 24-36 h the adherent monocytes could not be restimulated. Neither GM-CSF nor TNF could down-regulate the secretion of GM-CSF. IL-3 induced a minor secretion of GM-CSF whereas TNF, G-CSF, M-CSF and IFN-gamma were unable to induce GM-CSF secretion. In addition to LPS and IL-1, GM-CSF and to a minor degree TNF induced G-CSF secretion. Enriched T lymphocytes secreted GM-CSF, but not G-CSF, after stimulation with PHA or staphylococcal enterotoxin A (SEA), whereas LPS and IL-1 were without stimulatory effects. We also noted that enriched T lymphocytes added to LPS-stimulated adherent monocytes at ratios of 1:10 or more inhibited, in a dose-dependent fashion, GM-CSF secretion by 13-55%. These findings add new quantitative data on CSF secretion by human monocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281454     DOI: 10.1111/j.1600-0609.1992.tb00047.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  14 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  The granulocyte colony-stimulating factors (CSF3s) of fish and chicken.

Authors:  Mudjekeewis D Santos; Motoshige Yasuike; Ikuo Hirono; Takashi Aoki
Journal:  Immunogenetics       Date:  2006-04-28       Impact factor: 2.846

3.  Inflammatory mechanisms underlying the rat pulmonary neutrophil influx induced by airway exposure to staphylococcal enterotoxin type A.

Authors:  Ivani A Desouza; Carla F Franco-Penteado; Enilton A Camargo; Carmen S P Lima; Simone A Teixeira; Marcelo N Muscará; Gilberto De Nucci; Edson Antunes
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

4.  Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10.

Authors:  P M Seldon; M A Giembycz
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

5.  Antigen-specific regulation of CD1 expression in humans.

Authors:  M Ulanova; A Tarkowski; S A Porcelli; L A Hanson
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

6.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism.

Authors:  K K Meja; P M Seldon; Y Nasuhara; K Ito; P J Barnes; M A Lindsay; M A Giembycz
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 8.  Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.

Authors:  Natalie E Duran; Daniel W Hommes
Journal:  Therap Adv Gastroenterol       Date:  2016-04-25       Impact factor: 4.409

Review 9.  The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis.

Authors:  Irene Mavroudi; Helen A Papadaki
Journal:  ScientificWorldJournal       Date:  2011-10-26

10.  Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses.

Authors:  Katherine T Morris; Eliseo F Castillo; Anita L Ray; Lea L Weston; Robert A Nofchissey; Joshua A Hanson; Von G Samedi; Irina V Pinchuk; Laurie G Hudson; Ellen J Beswick
Journal:  Oncotarget       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.